| Rethinking peripheral T cell tolerance: checkpoints across a T cell’s journey MA ElTanbouly, RJ Noelle Nature Reviews Immunology, 2020 | 240 | 2020 |
| VISTA is a checkpoint regulator for naïve T cell quiescence and peripheral tolerance MA ElTanbouly, Y Zhao, E Nowak, J Li, E Schaafsma, I Le Mercier, ... Science 367 (6475), eaay0524, 2020 | 237 | 2020 |
| VISTA: a novel immunotherapy target for normalizing innate and adaptive immunity MA ElTanbouly, W Croteau, RJ Noelle, JL Lines Seminars in immunology 42, 101308, 2019 | 139 | 2019 |
| VISTA: Coming of age as a multi-lineage immune checkpoint MA ElTanbouly, E Schaafsma, RJ Noelle, JL Lines Clinical & Experimental Immunology 200 (2), 120-130, 2020 | 111 | 2020 |
| Germinal center–dependent and–independent memory B cells produced throughout the immune response C Viant, T Wirthmiller, MA ElTanbouly, ST Chen, EE Kara, M Cipolla, ... Journal of Experimental Medicine 218 (8), 2021 | 84 | 2021 |
| Pro-fibrotic Activation of Human Macrophages in Systemic Sclerosis Rajan Bhandari, Michael S. Ball, Viktor Martyanov, Dillon Popovich, Evelien ... Arthritis & Rheumatology, 2020 | 79* | 2020 |
| Defining the signature of VISTA on myeloid cell chemokine responsiveness TWK Broughton, MA ElTanbouly, E Schaafsma, J Deng, A Sarde, ... Frontiers in immunology 10, 2641, 2019 | 52 | 2019 |
| Continuous germinal center invasion contributes to the diversity of the immune response T Hägglöf, M Cipolla, M Loewe, ST Chen, EE Kara, L Mesin, H Hartweger, ... Cell 186 (1), 147-161. e15, 2023 | 51 | 2023 |
| VISTA: a target to manage the innate cytokine storm MA ElTanbouly, Y Zhao, E Schaafsma, CM Burns, R Mabaera, C Cheng, ... Frontiers in immunology 11, 595950, 2021 | 43 | 2021 |
| VISTA re-programs macrophage biology through the combined regulation of tolerance and anti-inflammatory pathways MA ElTanbouly, E Schaafsma, NC Smits, P Shah, C Cheng, C Burns, ... Frontiers in immunology 11, 580187, 2020 | 41 | 2020 |
| VISTA targeting of T-cell quiescence and myeloid suppression overcomes adaptive resistance E Schaafsma, W Croteau, M ElTanbouly, EC Nowak, NC Smits, J Deng, ... Cancer immunology research 11 (1), 38-55, 2023 | 29 | 2023 |
| CDDO-Me alters the tumor microenvironment in estrogen receptor negative breast cancer MS Ball, R Bhandari, GM Torres, V Martyanov, MA ElTanbouly, ... Scientific Reports 10 (1), 6560, 2020 | 26 | 2020 |
| Role of affinity in plasma cell development in the germinal center light zone MA ElTanbouly, V Ramos, AJ MacLean, ST Chen, M Loewe, S Steinbach, ... Journal of Experimental Medicine 221 (1), 2024 | 15 | 2024 |
| Memory B cell development elicited by mRNA booster vaccinations in the elderly Z Wang, F Muecksch, R Raspe, F Johannsen, M Turroja, M Canis, ... Journal of Experimental Medicine 220 (9), e20230668, 2023 | 10 | 2023 |
| Affinity maturation of antibody responses is mediated by differential plasma cell proliferation AJ MacLean, LP Deimel, P Zhou, MA ElTanbouly, J Merkenschlager, ... Science 387 (6732), 413-420, 2025 | | 2025 |
| Heterogeneity and plasticity of the naïve CD4+ T cell compartment JL Lines, A Sajani, E Schaafsma, W Croteau, M ElTanbouly, E Nowak, ... | | 2025 |
| The role of VISTA engagement in limiting neutrophil-mediated inflammation EC Nowak, J Li, MA ElTanbouly, WL Davis III, P Sergent, LK Mendyka, ... bioRxiv, 2024.05. 05.592601, 2024 | | 2024 |
| Smits NC, Shah P, Cheng C, Burns C, Blazar BR, Noelle RJ and Mabaera R (2020) VISTA Re-programs Macrophage Biology Through the Combined Regulation of Tolerance and Anti … MA ElTanbouly, E Schaafsma Emerging Therapeutics for Immune Tolerance, 5801875, 2021 | | 2021 |
| VISTA Is a Checkpoint Regulator of T Cell and Myeloid Cell Activities MA ElTanbouly Dartmouth College, 2020 | | 2020 |
